SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker

키워드

참고문헌 (26)

1. Paci E, "Mortality, survival and incidence rates in the ITALUNG randomized lung cancer screening trial", Thorax, 72, pp.825~831 (2017)
2. Parkin DM, "Global cancer statistics", CA Cancer J Clin, 55, pp.74~108 (2002)
3. Molina JR, "Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship", Mayo Clin Proc, 83, pp.584~594 (2008)
4. Stenman UH, "Tumor-associated trypsin inhibitor", Clin Chem, 48, pp.1206~1209 (2002)
5. Itkonen O, "TATI as a biomarker", Clin Chim Acta, 431, pp.260~269 (2014)
6. Stenman UH, "Immunochemical demonstration of an ovarian cancer-associated urinary peptide", Int J Cancer, 30, pp.53~57 (1982)
7. Scheving LA, "Primary amino acid sequence similarity between human epidermal growth factorurogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family", Arch Biochem Biophys, 226, pp.411~413 (1983)
8. Ateeq B, "Therapeutic targeting of SPINK1-positive prostate cancer", Sci Transl, 3 (2011)
9. Ida S, "SPINK1 status in colorectal cancer, impact on proliferation, and role in colitis-associated cancer", Mol Cancer Res, 13, pp.1130~1138 (2015)
10. Tiwari R, "SPINK1promotes colorectal cancer progression by downregulating Metallothioneins expression", Oncogenesis, 10(4), pp.e162~ (2015)
11. Zhang J, "The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line", Tumour Biol, 37, pp.5847~5855 (2016)
12. Mehner C, "Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers", Oncotarget, 6, pp.35737~35754 (2015)
13. Ateeq B, "Therapeutic targeting of SPINK1-positive prostate cancer", Sci Transl Med, 3 (2011)
14. Chen YT, "Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation of colorectal cancer through the epidermal growth factor as a prognostic marker", Pathol Oncol Res, 21, pp.1201~1208 (2015)
15. El-mezayen HA, "A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer", Tumour Biol, 35, pp.2759~2767 (2014)
16. Ozaki N, "Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor", Mol Cancer Res, 7, pp.1572~1581 (2009)
17. Gaber A, "High expression of tumour associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer", Br J Cancer, 100, pp.1540~1548 (2009)
18. Tomlins SA, "The role of SPINK1 in ETS rearrangement-negative prostate cancers", Cancer Cell, 13, pp.519~528 (2008)
19. Ying HY, "Serine protease inhibitor Kazal type 1(SPINK1)downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK", ERK signaling pathway, 2017, pp.18, 349~358
20. Tania M, "Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer", Tumour Biol, 35, pp.7335~7342 (2014)
21. Chakraborti S, "Regulation of matrix metalloproteinases: an overview", Mol Cell Biochem, 253, pp.269~285 (2003)
22. O-charoenrat P, "Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinama cells", Cancer Res, 9(60), pp.1121~1128 (2000)
23. Lv FZ, "Knockdown of MMP12inhibits the growth and invasion of lung adenocarcinoma cells", Int J Immunopathol Pharmacol, 28, pp.77~84 (2015)
24. Flavin R, "SPINK1 protein expression and prostate cancer progression", Clin Cancer Res, 20, pp.4904~4911 (2014)
25. Zhang X, "The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis", Onco Targets Ther, 10, pp.3123~3130 (2017)
26. Räsänen K, "Emerging Roles of SPINK1 in Cancer", Clin Chem, 62, pp.449~457 (2016)

관련 논문AI추천